Samuel Santiago, PhD, MBA
Executive Director
Global Biotech Strategies
Over 15 Years Working with Global Leaders , D.C., New York, London, Dubai, São Paulo, Beijing
Dr. Samuel is an Advisor to the White House Council on Science and Technology: Next Generation innovation in Medical, Automation Systems and Education Technology Platforms. He is also an Advisor and confidant to CEOs, CFOs, CIOs, CMOs and Board of Directors. Providing Design to Value strategy for governance, process, standard, Tool / system and measurement.
He is also an Advisor to Investment groups on the next R&D technology opportunities with organizations like Black Stone, Carlyle Group, Bridgewater, Investment Corporation of Dubai, Vatican Bank, Asian Infrastructure Investment Bank, Abu Dhabi Investment Authority and others. Dr. Samuel is been the Subject Matter Expert to the top Consulting Groups: McKinsey, Boston Consulting Group, Bain, Booz Allen Hamilton, Strategy & PwC, Deloitte, L.E.K., Ernst & Young, Accenture and others; providing trade wind visibility of incoming strategic inflection points. He also helps startups leveraging asset base tools for lean start up or a global fortune 100. High level network knowledge exchange with scientific, technology and industry leaders worldwide. Cultivating passionate tribes of Key Opinion Leaders.
Dr. Samuel is a Technology leader assessing the complex needs for the NIH Accelerated Medicine Partnership made up of 10 pharmaceutical companies that focused on streamlining process and smart technologies to create target validation for diagnostic and drug treatments. Dr. Samuel is also the Member of National Response Team for Pandemic and All-Hazards Preparedness Joint Command and Control with DHL, DoD / BARDA (Biological Advance Research and Development Authority) and the CDC.
Dr. Samuel is an Advisor to the White House Council on Science and Technology: Next Generation innovation in Medical, Automation Systems and Education Technology Platforms. He is also an Advisor and confidant to CEOs, CFOs, CIOs, CMOs and Board of Directors. Providing Design to Value strategy for governance, process, standard, Tool / system and measurement.
He is also an Advisor to Investment groups on the next R&D technology opportunities with organizations like Black Stone, Carlyle Group, Bridgewater, Investment Corporation of Dubai, Vatican Bank, Asian Infrastructure Investment Bank, Abu Dhabi Investment Authority and others. Dr. Samuel is been the Subject Matter Expert to the top Consulting Groups: McKinsey, Boston Consulting Group, Bain, Booz Allen Hamilton, Strategy & PwC, Deloitte, L.E.K., Ernst & Young, Accenture and others; providing trade wind visibility of incoming strategic inflection points. He also helps startups leveraging asset base tools for lean start up or a global fortune 100. High level network knowledge exchange with scientific, technology and industry leaders worldwide. Cultivating passionate tribes of Key Opinion Leaders.
Dr. Samuel is a Technology leader assessing the complex needs for the NIH Accelerated Medicine Partnership made up of 10 pharmaceutical companies that focused on streamlining process and smart technologies to create target validation for diagnostic and drug treatments. Dr. Samuel is also the Member of National Response Team for Pandemic and All-Hazards Preparedness Joint Command and Control with DHL, DoD / BARDA (Biological Advance Research and Development Authority) and the CDC.
Webinars Conducted By Samuel Santiago, PhD, MBA
Content Disclaimer
Contents in our website are from external websites. Links to and content from external website are provided for the convenience of users. Biopractice.com takes no responsibility for the content of such links and websites.